ストックスクリーナーアプリを入手
4.88
17.59%
0.73
プレマーケット:
4.81
-0.07
-1.43%
前日終値:
$4.15
開ける：
$4.14
24時間の取引高:
1.18M
Relative Volume:
2.19
時価総額：
$163.86M
収益：
-
当期純損益:
$-14.14M
株価収益率:
-5.3043
EPS:
-0.92
ネットキャッシュフロー:
$-12.64M
1週間 パフォーマンス:
+13.49%
1か月 パフォーマンス:
+46.55%
6か月 パフォーマンス:
+136.89%
1年 パフォーマンス:
+111.26%
1日の値動き範囲:
$4.07
$5.08
1週間の範囲:
$3.78
$5.08
52週間の値動き範囲:
$1.34
$5.08
Immix Biopharma Inc Stock (IMMX) Company Profile
名前
Immix Biopharma Inc
セクター
電話
(888) 958-1084
住所
11400 WEST OLYMPIC BLVD., LOS ANGELES
IMMX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
4.88 | 139.35M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immix Biopharma Inc (IMMX) 最新ニュース
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher – What’s Next? - Defense World
What analysts say about Immix Biopharma Inc stockSector Rotation Strategies & Our Experts Decode Market Noise for You - earlytimes.in
Is Immix Biopharma Inc a good long term investmentMarket Depth Overview & Watch and Learn From Live Trades - earlytimes.in
Will Immix Biopharma Inc. stock benefit from automationJuly 2025 Catalysts & Accurate Intraday Trade Tips - BỘ NỘI VỤ
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch - MSN
A significant driver of top-line growth: Immix Biopharma Inc (IMMX) - Setenews
Immix Biopharma Updates Accounting Firm Consents - MSN
Immix Biopharma files updated auditor consents for SEC registration statement - Investing.com Nigeria
Immix Biopharma Inc. (IMMX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Immix Biopharma Updates Auditor Consents for Registration Statement - TradingView
[8-K] Immix Biopharma, Inc. Reports Material Event | IMMX SEC FilingForm 8-K - Stock Titan
Is Variman Global Enterprises Limited Worth Holding Through Market ReversalDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
We Think Immix Biopharma (NASDAQ:IMMX) Needs To Drive Business Growth Carefully - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Will Immix Biopharma Inc. stock rally after Fed decisionsQuarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Working capital per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Can trapped investors hope for a rebound in Immix Biopharma Inc.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
How rising interest rates impact Immix Biopharma Inc. stockPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis - MSN
Will Immix Biopharma Inc. see short term momentum2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
How Immix Biopharma Inc. stock valuations compare to rivalsJuly 2025 Trends & Safe Capital Growth Tips - newser.com
ETFs Investing in Immix Biopharma, Inc. Stocks - TradingView
What the charts say about Immix Biopharma Inc. todayMarket Rally & AI Enhanced Execution Alerts - newser.com
How Immix Biopharma Inc. stock reacts to bond yieldsPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Immix Biopharma Inc. stock trendline breakdownEarnings Trend Report & Weekly High Conviction Ideas - newser.com
Immix Biopharma Inc Stock Analysis and ForecastEarnings Beat Highlights & Free Expert Guidance For Growth - earlytimes.in
Why Immix Biopharma Inc. stock appeals to dividend seekers2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Will Immix Biopharma Inc. stock sustain high P E ratiosEarnings Trend Report & Consistent Income Trade Recommendations - Fundação Cultural do Pará
A History of Outperforming Analyst Forecasts and Beating the Odds: Immix Biopharma Inc (IMMX) - Setenews
Best Biotech Stocks Right Now • Updated Daily - Benzinga
Risk adjusted return profile for Immix Biopharma Inc. analyzedJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Immix Biopharma appoints Grabow as Chief Commercial Officer - MSN
EBIT per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma appoints commercial leader to head NXC-201 launch By Investing.com - Investing.com Australia
HC Wainwright Comments on Immix Biopharma FY2025 Earnings - Defense World
Immix Biopharma Inc (IMMX) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):